Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Exhaled Nitric Oxide, Inflammatory Markers in Exhaled Breath Condensate and Conventional Parameters

NCT00402207 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00402207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Exhaled Nitric Oxide, Inflammatory Markers in Exhaled Breath Condensate and Conventional Parameters
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2005
Completion date
October 31, 2006
Enrollment
33
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma